Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1984-06-04
1985-12-10
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
A61K 3700
Patent
active
045580375
ABSTRACT:
A cardiovascular composition is disclosed which comprises either dibenzo-thiepin derivatives alone or the combination of dibenzo-thiepin derivatives and angiotensin converting enzyme (ACE) inhibitors. These compositions represent a novel therapeutic approach to thromboembolic disease in man.
REFERENCES:
patent: 4052511 (1977-10-01), Cushman et al.
patent: 4129571 (1978-12-01), Ondetti et al.
patent: 4154960 (1979-05-01), Ondetti et al.
patent: 4237160 (1980-12-01), Hamel et al.
patent: 4334077 (1982-06-01), Belanger et al.
patent: 4374829 (1983-02-01), Harris et al.
patent: 4394515 (1983-07-01), Rokach et al.
patent: 4424355 (1984-01-01), Belanger et al.
patent: 4435579 (1984-03-01), Belanger et al.
J. D. Pearson, et al., Thrombasis Research, 29, 115-124 (1983).
K. M. Mullane, et al., Eur. J. Phar., 66, 355-365 (1980).
C. C. Chan, et al., J. Pharmacol. Expt. Ther., 229, 276-282 (1984).
Chan Chi-Chung
Ford-Hutchinson Anthony W.
Merck & Co. , Inc.
Mitri Salvatore C.
Phillips Delbert R.
Sudol Michael C.
LandOfFree
Cardiovascular composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cardiovascular composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiovascular composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-58963